CODX vs TXN
Co-Diagnostics, Inc. Common Stock (CODX) versus Texas Instruments Incorporated (TXN) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Texas Instruments Incorporated (TXN) is a semiconductors company listed on NASDAQ.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TXN revenue for 2025-12-31 was $17.68B. Net income was $5.00B. Revenue was up 13.0% from 2024-12-31 to 2025-12-31. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
CODX currently screens at market cap $31.4M. TXN currently screens at market cap $274.74B and trailing P/E 51.7.
Not investment advice. Open the CODX and TXN stock pages for the full models.
Not investment advice.